Facebook Pixel Code

Zydus Lifesciences Ltd. Share Price

NSE
BSE
FUT
OPT

ZYDUS LIFESCIENCES LTD.

Sector : Pharmaceuticals | Largecap | BSE

Zydus Lifesciences Ltd., operating in the Pharmaceuticals sector and classified as a Largecap on the bse, currently has its share price at 1070.35 The stock has experienced fluctuations today, with a low of ₹1059 and a high of ₹1079.8 Over the past 52 weeks, the shares have seen a low of ₹564.05 and a high of ₹1171.95.

In terms of performance, Zydus Lifesciences Ltd. has shown a return of 0.32% in one day, 3.69% over the past month, and 7.8% in the last three months.

Analyzing the technicals, the daily pivot level for the stock is set at 1069.72. The resistance levels are identified as R1 at 1080.43, R2 at 1090.52, and R3 at 1101.23. On the support side, the levels are marked as S1 at 1059.63, S2 at 1048.92, and S3 at 1038.83.

In the realm of technical analysis for our subject stock, the moving averages present a detailed picture. Over a short span of 5 days, the Simple Moving Average (SMA) stands at 1091.84, while the Exponential Moving Average (EMA) is noted at 1070.96. Extending the view to a 10-day period, the SMA adjusts to 1069.85 with the EMA slightly differing at 1072.87.

In a comparative analysis of stock performance within its sector, Zydus Lifesciences Ltd. stands alongside several key competitors, each showcasing varied performance metrics over different time periods. Zydus Lifesciences Ltd. itself has recorded performance figures of 1W % is 0.35 over the past week, 3.69% in the last month, and 8.47% over the past three months. Its six-month, one-year, three-year, and five-year performances are 6 month % is 50.8, 1yr % is 85.09, 3Y % is 66.29, and 5Y % is 351.53 respectively.

Read More  

₹1,070.35 Closed
0.323.4
As on Jul 2, 2024, 4:01 PM | IST
Intraday
1 Week
1 Month
3 Months
6 Months
1 Year

Zydus Lifesciences Ltd. Performance

Today's LowToday's High
₹1,059.00₹1,079.80
₹1,070.35
52 Weeks' Low52 Weeks' High
₹564.05₹1,171.95
₹1,070.35
Open Price
₹1,072.55
Prev. Close
₹1,066.95
Volume
23,152

Zydus Lifesciences Ltd. Technicals

Pivot Level

  • R11,080.43
  • R21,090.52
  • R31,101.23
  • Pivot
    1,069.72
  • S11,059.63
  • S21,048.92
  • S31,038.83

Moving Average

  • DaySMAEMA
  • 51,091.841,070.96
  • 101,069.851,072.87
  • 201,061.761,067.01
  • 501,013.221,033.9
  • 100955.05967.89
  • 200795.29856.77

Zydus Lifesciences Ltd. Peer Comparision

Stock Performance
Ratio Performance
Name
1W%
1M%
3M%
6M%
1Y%
3Y%
5Y%
0.353.698.4750.8085.0966.29351.53
0.054.76-6.1617.2847.50123.74284.80
0.595.7924.0813.4427.360.20180.56
0.562.431.1614.4648.5952.62169.01
4.9410.114.027.3824.8615.00145.22
1.025.308.9119.8849.0791.64263.58
-0.310.22-8.74-1.2025.5549.5549.55
3.073.101.7816.1582.9941.17116.94
1.26-0.926.9111.3370.6521.29103.93
-0.622.180.67-5.8041.2051.64186.88
-0.396.133.0416.7318.3863.73212.42
0.295.0733.2526.7984.8273.37121.82
1.2915.3230.8926.2235.44-11.5643.30
1.836.2325.6739.1389.3288.63181.67
1.93-1.531.82-10.3870.74-47.76-0.03
2.490.70-7.342.2451.9311.30136.81
-3.08-3.12-0.630.8152.6356.60251.98
3.830.586.265.3651.4989.86881.06
2.392.45-0.511.7922.48-36.12522.62
1.3519.2719.5343.0771.683.15122.44

Zydus Lifesciences Ltd. Share Holdings

Zydus Lifesciences Ltd. Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested
(in ₹ crore)
Kotak Flexicap Fund - Regular Plan1,09,00,0002.251,090.16
Parag Parikh Flexi Cap Fund76,78,8471.16768
ICICI Prudential Focused Equity Fund28,71,6923.53287.21
ICICI Prudential Bluechip Fund27,35,1680.49273.56
Nippon India Pharma Fund27,00,6323.77270.1
Sundaram Mid Cap Fund23,69,3712.15236.97
Sundaram Mid Cap Fund - Institutional Plan23,69,3712.15236.97
Kotak Equity Arbitrage Fund - Regular Plan19,82,7000.43198.3
Quant Mid Cap Fund18,01,0002.26180.13
Kotak Balanced Advantage Fund16,57,7601.05165.8
View All Mutual Funds

Futures

  • Price
      (%)
    As on Invalid Date | IST
  • Open Interest
      (%)
  • High
  • Low
  • Open
  • Close
  • Contract Traded
  • Turnover (in lakhs)

Options

  • Price
      (%)
    Not traded today
  • Open Interest
      (%)
  • High
  • Low
  • Open
  • Close
  • Contract Traded
  • Turnover (in lakhs)

Zydus Lifesciences Ltd. Corporate Actions

Announcement
Board Meetings
Dividend
Bonus
Splits
AGM
  • Zydus Lifesciences - Receipt Of Rectification Order Under Section 154 Of The IT Act
    Receipt of Rectification Order under section 154 of the IT Act
    01-Jul, 2024 | 05:36 PM
  • Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Zydus and Dr. Reddy''s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India.
    28-Jun, 2024 | 05:32 PM
  • Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Participation in Jefferies Corporate Access Day in Ahmedabad
    16-Jun, 2024 | 04:18 PM
  • Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Zydus receives tentative approval from USFDA for Azilsartan Medoxomil and Chlorthalidone Tablets.
    14-Jun, 2024 | 12:19 AM
  • Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Acquisition
    Acquisition of shares
    31-May, 2024 | 04:36 PM

About Zydus Lifesciences Ltd.

Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 7981.90 Cr. and Equity Capital is Rs. 102.40 Cr. for the Year ended 31/03/2022.

Management

  • Mr. Pankaj R Patel
    Chairman
  • Dr. Sharvil P Patel
    Managing Director
  • Mr. Ganesh N Nayak
    Executive Director
  • Mr. Bhadresh K Shah
    Independent Director
  • Mr. Mukesh M Patel
    Non Executive Director
  • Mr. Nitin R Desai
    Independent Director
  • Ms. Dharmishtaben N Raval
    Independent Woman Director
  • Ms. Apurva S Diwanji
    Independent Director
  • Mrs. Upasana Konidela
    Independent Woman Director
  • Mr. Monappa Arun Akhil
    Independent Director

FAQs on Zydus Lifesciences Ltd.

What is the Market Cap of Zydus Lifesciences Ltd.?

The market cap of Zydus Lifesciences Ltd. is ₹1,07,360.14 Cr as on Jul 02, 2024.

What is the PE and PB Ratio of Zydus Lifesciences Ltd.?

P/E ratio of Zydus Lifesciences Ltd. is 27.02 and PB ratio of Zydus Lifesciences Ltd. is 5.41 as on Jul 02, 2024.

What is the share price of Zydus Lifesciences Ltd.?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Zydus Lifesciences Ltd. is ₹1,70.35 as on Jul 02, 2024.

What are the 52 Week High and 52 Week Low of Zydus Lifesciences Ltd.?

The 52-week high/low is the highest and lowest price at which Zydus Lifesciences Ltd. stock has traded in the past 52-week or nearly a year. The 52-week high of Zydus Lifesciences Ltd. is ₹1,171.95 and 52-week low of Zydus Lifesciences Ltd. is ₹564.05 as on Jul 02, 2024.

icon
Market Data